✦ LIBER ✦

A study of amsalog (CI-921) administered orally on a 5-day schedule, with bioavailability and pharmacokinetically guided dose escalation

✍ Scribed by D. Fyfe, F. Raynaud, R. Langley, D. Newell…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacokinetic study of XR1

✍ de Jonge, M J A; Kaye, S; Verweij, J; Brock, C; Reade, S; Scurr, M; van Doorn, L 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB

27 ORAL Phase I dose escalation study of

✍ M. De Jonge; N. Steeghs; J. Verweij; J.W.R. Nortier; F. Eskens; J. Ouwerkerk; C. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 82 KB

A Randomized, Open-Label, 5-Period, Bala

✍ Mary Beth Wire; Jennifer Bruce; Jennifer Gauvin; Carolyn J. Pendry; Sandra McGui 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 449 KB